Walleye Trading
AXDX

Walleye Trading’s Accelerate Diagnostics AXDX Stock Holding History

Walleye Trading’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,910
Closed -$111K – 5345
2021
Q3 		$111K Sell
1,910
-250
-12% -$16.3K ﹤0.01% 4305
2021
Q2 		$174K Buy
2,160
+610
+39% +$48.5K ﹤0.01% 4034
2021
Q1 		$129K Buy
+1,550
New +$157K ﹤0.01% 3957
2020
Q2 		– Sell
-1,670
Closed -$139K – 4224
2020
Q1 		$139K Buy
+1,670
New +$235K ﹤0.01% 2901
2019
Q2 		– Sell
-1,200
Closed -$252K – 4018
2019
Q1 		$252K Buy
+1,200
New +$225K ﹤0.01% 2852

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Walleye Trading's AXDX Position: Q2 2020 in Review

Walleye Trading sold out of Accelerate Diagnostics (AXDX) in Q2 2020, closing a stake of 274 shares — an estimated $23K sold.

Walleye Trading first reported a position in AXDX in Q1 2020 and held it in 1 quarter. The position peaked at $23K in Q1 2020. 123 funds tracked by Wall St. Rank hold AXDX as of Q2 2020.

  • Walleye Trading reported no remaining Accelerate Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 274 Accelerate Diagnostics shares in Q2 2020, an estimated $23K.
  • Walleye Trading first reported a position in Accelerate Diagnostics in Q1 2020 and held it in 1 quarter.
  • Walleye Trading's Accelerate Diagnostics position peaked at $23K in Q1 2020.
  • 123 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.